Tiwa Adebayo
speaker
1,307 appearances
134 recordings
1 series
first heard Jan 2026
last heard today
Tiwa Adebayo’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 134 in all, peaking in Aug 2026 with 41.
Appearances
The merger could provide AstraZeneca with a bigger foothold in the US market, complementing its more than $260 billion valuation.
voice-verified
Meanwhile, Bristol Myers Squibb is preparing for the loss of patent protection for some of its biggest products, including a blood thinner and cancer drug, which make up about half of its sales.
voice-verified
In London, Tiwa Adebayo, Bloomberg Radio.
voice-verified
AstraZeneca and Bristol-Myers Squibb have reportedly held early stage discussions about combining.
voice-verified
Bloomberg understands that it's unclear whether the conversations are ongoing or if they will result in a transaction, but any agreement would be significant.
voice-verified
The merger could provide AstraZeneca with a bigger foothold in the U.S.
voice-verified
market, complementing its more than $260 billion valuation.
voice-verified
Meanwhile, Bristol-Myers Squibb is preparing for the loss of patent protection for some of its biggest products, including a blood thinner and cancer drug, which make up about half of its sales.
voice-verified
In London, Tiwa Adebayo, Bloomberg Radio.
voice-verified
Bloomberg News Now · Oil Falls On US-Iran Hope, Yen Rises Amid Speculation, More · 3 Aug 2026
podcast
No, but my brother did inherit my non-classic car when I moved to New York, so.
voice-verified
Ew.
voice-verified
He still has not paid me for it.
voice-verified
Coming for you, Joey.
voice-verified
AstraZeneca and Bristol-Myers Squibb have reportedly held early stage discussions about combining.
voice-verified
Bloomberg understands that it's unclear whether the conversations are ongoing or if they will result in a transaction, but any agreement would be significant.
voice-verified
The merger could provide AstraZeneca with a bigger foothold in the U.S.
voice-verified
market, complementing its more than $260 billion valuation.
voice-verified
Meanwhile, Bristol-Myers Squibb is preparing for the loss of patent protection for some of its biggest products, including a blood thinner and cancer drug, which make up about half of its sales.
voice-verified
In London, Tiwa Adebayo, Bloomberg Radio.
voice-verified
Bloomberg News Now · Trump: Iran Talks to Begin Today, Yen Climbs Sharply, More · 3 Aug 2026
podcast
AstraZeneca and Bristol-Myers Squibb have reportedly held early stage discussions about combining.
voice-verified
Showing 541–560 of 1,307 · page 28 of 66
← Previous
Next →